Halozyme Therapeutic (NQ: HALO )
39.49
+0.52
(+1.33%)
Streaming Delayed Price
Updated: 11:43 AM EDT, Apr 24, 2024
Add to My Watchlist
Price and Volume
Detailed QuoteVolume | 150,254 |
Open | 38.98 |
Bid (Size) | 39.47 (2) |
Ask (Size) | 39.51 (3) |
Prev. Close | 38.97 |
Today's Range | 38.82 - 39.70 |
52wk Range | 29.85 - 45.00 |
Shares Outstanding | 142,334,900 |
Dividend Yield | N/A |
Top News
More NewsPerformance
More News
Read More
NASDAQ:HALO, a strong growth stock, setting up for a breakout.
February 21, 2024
Breaking Down Halozyme Therapeutics: 7 Analysts Share Their Views
February 21, 2024
The 3 Best Biotech Stocks to Buy in Q2 2024
March 29, 2024
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
March 13, 2024
Halozyme Therapeutics: Q4 Earnings Insights
February 20, 2024
Earnings Preview: Halozyme Therapeutics
February 19, 2024
Looking for growth without the hefty price tag? Consider NASDAQ:HALO.
February 19, 2024
Earnings Scheduled For February 20, 2024
February 20, 2024
NASDAQ:HALO, an undervalued stock with good fundamentals.
February 09, 2024
NASDAQ:HALO, a strong growth stock, setting up for a breakout.
January 31, 2024
NASDAQ:HALO: good value for what you're paying.
January 19, 2024
3 Biotech Stocks to Sell in January Before They Crash and Burn
January 25, 2024
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.